rhinoviru
rv
respons
major
common
cold
also
caus
exacerb
patient
asthma
chronic
obstruct
pulmonari
diseas
far
drug
avail
treatment
rhinoviru
infect
examin
effect
quercetin
plant
flavanol
rv
infect
vitro
vivo
pretreat
airway
epitheli
cell
quercetin
decreas
akt
phosphosphoryl
viral
endocytosi
respons
addit
quercetin
h
rv
infect
viral
endocytosi
reduc
viral
load
ifn
respons
airway
epitheli
cell
associ
decreas
level
neg
posit
strand
viral
rna
rv
capsid
protein
abrog
rvinduc
cleavag
increas
phosphoryl
mice
infect
rv
quercetin
treatment
decreas
viral
replic
well
express
chemokin
cytokin
quercetin
treatment
also
attenu
rvinduc
airway
cholinerg
hyperrespons
togeth
result
suggest
quercetin
inhibit
rv
endocytosi
replic
airway
epitheli
cell
multipl
stage
rv
life
cycl
quercetin
also
decreas
express
proinflammatori
cytokin
improv
lung
function
rvinfect
mice
base
observ
studi
examin
potenti
benefit
quercetin
prevent
treatment
rv
infect
warrant
rhinoviru
rv
singlestrand
rna
viru
picornavirida
famili
respons
major
upper
respiratori
tract
infect
makela
et
al
winther
although
rv
infect
caus
mild
diseas
selflimit
normal
individu
repres
signific
econom
burden
particularli
loss
work
hour
miss
school
day
proud
accumul
evid
also
suggest
rv
import
trigger
acut
exacerb
patient
chronic
obstruct
pulmonari
diseas
copd
asthma
johnston
et
al
seemung
et
al
seemung
et
al
experiment
rv
infect
asthma
copd
patient
result
develop
lower
respiratori
diseas
airflow
obstruct
system
airway
inflamm
greater
prolong
similarlyinfect
control
subject
mallia
et
al
mallia
et
al
messag
et
al
clinic
outcom
experiment
rv
infect
correl
viral
load
inflammatori
cytokin
sputum
bronchoalveolar
lavag
current
therapi
treat
virusrel
acut
exacerb
asthma
copd
partial
effect
may
also
side
effect
similarli
current
avail
therapi
may
reliev
symptom
fdaapprov
drug
exist
treatment
rv
infect
therefor
antivir
drug
possess
antiinflammatori
activ
time
effect
inhibit
viral
replic
may
benefici
treat
rv
infect
rv
life
cycl
offer
mani
opportun
intervent
initi
stage
viral
life
cycl
involv
bind
cell
surfac
receptor
endocytosi
acidif
endosom
viral
uncoat
releas
viral
rna
vrna
cytoplasm
prchla
et
al
next
stage
vrna
translat
singl
larg
polyprotein
intern
ribosom
entri
site
ire
locat
untransl
region
rv
genom
polyprotein
process
sequenti
enzymat
cleavag
two
virusencod
proteinas
proteinas
foeger
et
al
hellen
et
al
simultan
transcript
viral
genom
catalyz
virusencod
rna
polymeras
begin
meredith
et
al
final
stage
viral
replic
rna
capsid
protein
assembl
matur
viral
particl
releas
cell
lysi
replic
process
rna
virus
includ
rv
modifi
cellular
function
advantag
exampl
rv
proteinas
attack
host
translat
machineri
suscept
hela
cell
cleav
eukaryot
initi
factor
eif
therebi
shut
capdepend
host
cell
protein
synthesi
glaser
skern
gradi
et
al
drug
interfer
step
would
benefici
treat
rv
infect
virus
also
interfer
host
defens
mechan
upon
viral
infect
host
cell
neg
regul
global
protein
translat
order
limit
viral
replic
protein
kinas
r
pkr
activ
viral
doublestrand
ds
rna
phosphoryl
phosphoryl
therebi
inhibit
translat
host
vrna
jacob
langland
qian
et
al
nonstructur
protein
respiratori
syncyti
viru
influenza
viru
hepat
viru
competit
inhibit
bind
pkr
therebi
inhibit
phosphoryl
gale
et
al
groskreutz
et
al
li
et
al
tan
katz
convers
revers
inhibit
would
augment
viral
clearanc
quercetin
plant
flavonoid
present
mani
plant
includ
broccoli
appl
berri
onion
tea
flavonoid
share
common
chemic
structur
consist
two
phenol
ring
link
three
carbon
quercetin
potent
antioxid
effect
combin
free
radic
speci
form
consider
less
reactiv
phenoxi
radic
quercetin
also
inhibitori
effect
sever
lipid
protein
tyrosin
serinethreonin
kinas
includ
phosphatidylinositol
pi
induc
nitric
oxid
synthas
agullo
et
al
davi
et
al
huang
et
al
jiang
et
al
peet
li
quercetin
also
shown
exert
antivir
activ
vitro
quercetin
deriv
reduc
infect
replic
herp
simplex
viru
type
polioviru
type
parainfluenza
viru
type
adenoviru
respiratori
syncyti
viru
influenza
viru
vitro
castrillo
carrasco
chiang
et
al
kaul
et
al
kim
et
al
neznanov
et
al
among
sever
quercetin
deriv
examin
exhibit
potent
antirhinovir
effect
human
skin
fibroblast
de
meyer
et
al
howev
quercetin
antirhinovir
effect
studi
later
quercetin
shown
inhibit
sarscov
proteas
requir
sar
viru
replic
well
hepat
c
viral
protein
translat
releas
newli
form
viral
particl
gonzalez
et
al
quercetin
supplement
also
shown
reduc
suscept
influenza
viru
infect
sever
diseas
follow
stress
exercis
mice
davi
et
al
symptom
upper
respiratori
tract
infect
athlet
nieman
et
al
import
quercetin
supplement
increas
skelet
muscl
mitochondri
biogenesi
modestli
untrain
athlet
associ
improv
exercis
perform
nieman
et
al
sinc
mitochondria
orchestr
antivir
signal
follow
recognit
cytosol
viral
compon
tal
iwasaki
may
exist
relationship
quercetininduc
mitochondri
biogenesi
reduc
suscept
influenza
infect
although
associ
physic
stressfatigu
suscept
rv
infect
establish
rv
caus
sever
exacerb
patient
copd
asthma
mallia
et
al
mallia
et
al
messag
et
al
understand
mechan
quercetin
inhibit
rhinoviru
infect
replic
necessari
determin
suitabl
quercetin
treat
rv
infect
patient
present
studi
examin
effect
quercetin
treatment
rv
endocytosi
viral
genom
transcript
translat
proinflammatori
respons
vitro
also
assess
effect
quercetin
vivo
use
novel
mous
model
rv
infect
newcomb
et
al
purchas
american
type
cultur
collect
manassa
va
viral
stock
gener
describ
previous
newcomb
et
al
fifti
percent
cell
cultur
infect
dose
ccid
valu
viral
stock
determin
spearmankarb
method
johnston
tyrrel
gener
replicationdefici
viru
uvrv
rv
prepar
expos
ultraviolet
light
min
ice
mjcm
chattoraj
et
al
immort
human
bronchial
epitheli
cell
american
type
cultur
collect
cultur
bronchial
epitheli
cell
growth
medium
begm
lonza
walkersvil
md
collagenco
plate
describ
previous
chattoraj
et
al
wang
et
al
rv
infect
cell
grown
plate
confluenc
cell
infect
rv
multipl
infect
moi
base
ccid
incub
min
allow
bind
endocytosi
rv
infect
medium
replac
fresh
medium
incub
h
quercetin
dihydr
sigma
st
loui
mo
dmso
vehicl
control
ad
requir
concentr
incub
h
experi
cell
pretreat
quercetin
h
infect
rv
h
presenc
quercetin
infect
medium
replac
fresh
medium
contain
dmso
quercetin
select
experi
cell
pretreat
quercetin
dmso
overnight
shift
quercetin
free
medium
h
cell
rins
fresh
medium
infect
absenc
quercetin
endocytosi
rv
airway
epitheli
cell
measur
describ
previous
chattoraj
et
al
newcomb
et
al
briefli
cell
pretreat
quercetin
dmso
incub
rv
equal
volum
sham
cell
lysat
uninfect
hela
cell
min
cell
wash
incub
min
facilit
endocytosi
bound
rv
cell
permeabil
endocytos
rv
detect
antibodi
rv
capsid
protein
mosser
et
al
alexafluor
secondari
antibodi
quantifi
flow
cytometri
correct
sham
control
visual
endocytos
rv
cell
infect
incub
min
fix
cold
methanol
block
normal
donkey
serum
treat
antibodi
rv
capsid
protein
earli
endosom
antigen
eea
santa
cruz
biotechnolog
santa
cruz
ca
bound
antibodi
detect
alexafluor
rv
alexafluor
conjug
secondari
antibodi
cell
nuclei
counterstain
dapi
cell
visual
confoc
microscopi
eight
ten
weekold
mice
infect
sham
intranas
rout
gavag
mg
quercetin
daili
one
four
day
control
group
consist
similarli
infect
mice
treat
vehicl
propylen
glycol
pg
experi
mice
treat
quercetin
vehicl
day
two
day
last
treatment
mice
infect
rv
sham
experi
approv
anim
care
use
committe
univers
michigan
appropri
treatment
cell
along
medium
subject
one
freezethaw
cycl
centrifug
mice
sacrif
day
postinfect
lung
collect
asept
condit
homogen
ml
pb
lung
homogen
subject
two
freezethaw
cycl
centrifug
viral
titer
ccid
supernat
cell
cultur
lung
homogen
measur
describ
previous
protein
level
cytokin
cell
cultur
medium
lung
homogen
supernat
measur
multiplex
immunoassay
biorad
hercul
ca
elisa
r
system
minneapoli
mn
mice
anesthet
intraperiton
inject
ketamin
g
bodi
weight
pentobarbit
mg
g
bodi
weight
steel
cannula
insert
trachea
connect
miniatur
computer
ventil
buxco
finepoint
oper
system
wilmington
nc
airway
respons
methacholin
measur
nebul
increas
dose
methacholin
describ
previous
total
rna
isol
lung
cell
cultur
use
rneasi
qiagen
valencia
ca
cdna
synthes
util
first
strand
synthesi
kit
appli
biosystem
carlsbad
ca
mrna
level
ifna
ifnb
quantifi
realtim
pcr
use
gene
specif
primer
express
fold
increas
housekeep
gene
dehydrogenas
posit
strand
rv
rna
quantifi
qpcr
describ
previous
newcomb
et
al
sajjan
et
al
detect
neg
strand
rv
rna
lg
total
rna
convert
cdna
use
primer
specif
neg
strand
rv
rna
superscript
iii
revers
transcriptas
invitrogen
carlsbad
ca
describ
previous
newcomb
et
al
cdna
amplifi
qpcr
use
nest
primer
product
analyz
agaros
gel
electrophoresi
relev
treatment
cell
lyse
ripa
buffer
contain
complet
proteas
inhibitor
roch
diagnost
indianapoli
phosphatas
inhibitor
mm
sodium
fluorid
mm
sodium
orthovanad
cell
lysat
centrifug
total
protein
supernat
determin
equal
amount
protein
subject
sdspage
protein
transfer
nitrocellulos
membran
membran
block
either
bovin
serum
albumin
fatfre
milk
probe
antibodi
phosphoakt
total
akt
cell
signal
technolog
danver
abcam
cambridg
bactin
sigmaaldrich
st
loui
mo
bound
antibodi
detect
appropri
second
antibodi
conjug
horseradish
peroxidas
biorad
chemiluminesc
substrat
pierc
rockford
il
statist
analysi
signific
calcul
either
oneway
analysi
varianc
follow
tukey
posthoc
test
unpair
test
welch
correct
use
sigma
stat
softwar
systat
softwar
san
jose
ca
result
shown
mean
sd
sham
min
wash
remov
unbound
viru
cell
incub
min
endocytos
viru
detect
use
antibodi
rv
follow
flow
cytometri
b
data
repres
averag
sd
calcul
three
independ
experi
p
differ
sham
p
differ
media
dmso
treat
cell
c
cell
pretreat
dmso
quercetin
incub
min
cell
wash
incub
antibodi
rv
capsid
protein
green
antibodi
red
nuclei
counterstain
dapi
blue
cell
visual
confoc
microscopi
arrow
repres
coloc
cell
pretreat
quercetin
infect
sham
incub
min
total
cell
lysat
subject
western
blot
analysi
antibodi
pakt
total
akt
imag
blot
repres
three
independ
experi
previous
demonstr
cultur
airway
epitheli
cell
rv
bind
endocytosi
suffici
initi
respons
infect
newcomb
et
al
also
show
endocytosi
rv
requir
activ
sinc
quercetin
inhibit
activ
davi
et
al
determin
whether
quercetin
pretreat
inhibit
endocytosi
rv
quercetin
pretreat
significantli
decreas
endocytosi
cell
fig
b
observ
similar
attenu
endocytosi
uvrv
also
examin
coloc
earli
endosom
marker
confoc
microscopi
cell
inocul
sham
hela
cell
lysat
show
diffus
signal
cytoplasm
data
shown
cell
infect
show
cluster
rv
particl
cell
also
show
punctat
stain
oppos
diffus
stain
indic
recruit
endosom
cluster
rv
particl
frequent
coloc
endosom
indic
endocytosi
rv
cell
fig
contrast
cell
pretreat
quercetin
infect
show
distribut
similar
shamtreat
cell
faint
signal
rv
coloc
endosom
faint
signal
rv
may
repres
bound
endocytos
viru
result
suggest
pretreat
quercetin
may
block
endocytosi
rv
next
examin
whether
quercetin
inhibit
rvinduc
phosphoryl
akt
downstream
effector
observ
previous
treat
cell
show
increas
akt
phosphoryl
compar
shaminfect
cell
fig
quercetin
pretreat
complet
inhibit
rvinduc
akt
phosphoryl
result
indic
quercetin
decreas
rv
endocytosi
signal
lead
reduct
express
next
determin
endocytosisindepend
effect
airway
epitheli
cell
monolay
infect
incub
h
allow
time
viral
endocytosi
quercetin
dmso
ad
cell
cultur
medium
incub
anoth
h
cell
inocul
sham
serv
neg
control
cellular
mrna
level
ifnb
cell
supernat
protein
level
determin
observ
earlier
newcomb
et
al
wang
et
al
infect
stimul
significantli
higher
ifnb
uvirradi
viru
fig
contrast
cell
show
signific
increas
similar
intact
rv
fig
suggest
ifn
stimul
intact
replic
rv
quercetin
treatment
inhibit
rvstimul
ifn
well
express
consist
notion
quercetin
block
viral
replic
determin
whether
decreas
ifn
respons
due
decreas
viral
load
determin
viral
titer
cell
infect
dmso
quercetin
lm
ad
h
later
cell
incub
anoth
h
viral
titer
determin
h
postinfect
addit
quercetin
h
infect
h
ad
quercetin
expect
cell
infect
show
presenc
infecti
rv
shown
compar
h
infect
cell
infect
intact
show
increas
load
infecti
rv
h
postinfect
indic
replic
viru
cell
fig
twentyfour
hour
postinfect
cell
treat
quercetin
show
viral
load
log
lower
similarli
infect
vehicletr
cell
also
measur
viral
load
assess
vrna
level
expect
rvinfect
cell
show
significantli
increas
vrna
copi
number
compar
uvrvinfect
cell
fig
contrast
rvinfect
cell
treat
quercetin
show
vrna
copi
number
similar
infect
uvrv
result
consist
notion
quercetin
may
inhibit
viral
replic
viral
genom
amplif
negativestrand
vrna
gener
intermedi
therefor
monitor
negativestrand
rna
rvinfect
cell
pcr
observ
amplif
negativestrand
rna
cell
infect
cell
infect
replicationdefici
uvrv
fig
rvinfect
quercetintr
cell
negativestrand
rna
either
decreas
detect
impli
quercetin
may
inhibit
viral
replic
transcript
level
viral
replic
viral
proteas
cleav
inhibit
format
initi
complex
requir
host
capdepend
protein
synthesi
turn
facilit
translat
viral
protein
cell
infect
quercetin
dmso
ad
h
post
rv
infect
overnight
incub
cell
infect
intact
show
cleavag
cell
infect
sham
uvrv
treatment
quercetin
complet
abolish
cleavag
fig
increas
phosphoryl
limit
mrna
translat
global
essenti
inhibit
viral
replic
infect
cell
therefor
assess
phosphoryl
airway
epitheli
cell
infect
cell
infect
intact
show
increas
phosphoryl
compar
cell
inocul
sham
replicationdefici
uvrv
fig
show
previous
nanua
et
al
quercetin
treatment
increas
phosphoryl
togeth
result
impli
quercetin
may
decreas
viral
genom
translat
inhibit
cleavag
increas
phosphoryl
next
determin
whether
quercetin
decreas
viral
protein
level
examin
level
rv
capsid
protein
western
blot
analysi
shaminfect
cell
show
capsid
protein
rvinfect
cell
show
two
band
correspond
along
precursor
fig
quercetin
treat
cell
show
lower
amount
band
consist
notion
quercetininduc
chang
translat
initi
may
reduc
translat
viral
rna
next
examin
whether
withdraw
quercetin
h
prior
viral
infect
limit
viral
replic
associ
ifn
respons
cell
pretreat
quercetin
overnight
fig
quercetin
ad
h
rv
infect
decreas
viral
load
replic
cell
infect
treat
quercetin
describ
fig
cell
along
media
collect
ad
quercetin
h
h
addit
quercetin
dmso
rv
infect
infecti
viral
load
determin
total
rna
extract
cell
incub
total
h
post
rv
infect
use
determin
vrna
b
amplifi
qpcr
product
neg
strand
rna
subject
agaros
gel
electrophoresi
show
amplifi
negativestrand
vrna
c
result
repres
three
experi
p
differ
uvrv
b
differ
sham
p
differ
media
dmso
treat
cell
shift
quercetin
free
medium
eight
hour
later
cell
rins
medium
infect
absenc
quercetin
vrna
viral
titer
ifn
product
determin
although
cell
pretreat
quercetin
show
slightli
lower
viral
titer
vrna
vehicletr
cell
differ
statist
signific
fig
b
similarli
differ
ifn
level
quercetin
vehicl
treat
cell
observ
fig
surpris
quercetin
metabolit
level
cell
peak
h
post
treatment
slowli
reduc
time
complet
deplet
h
kim
et
al
kim
et
al
therefor
addit
quercetin
immedi
viral
infect
may
necessari
effect
limit
viral
infect
vitro
bind
intercellular
adhes
molecul
icam
infect
mous
cell
hand
bind
low
densiti
lipoprotein
receptor
ldlr
ldlrlike
receptor
infect
mous
airway
epitheli
cell
vitro
vivo
mice
infect
show
presenc
negativestrand
viral
rna
lung
transmiss
rv
infect
lung
homogen
inocul
mice
cultur
hela
cell
induct
robust
lung
ifn
respons
newcomb
et
al
sajjan
et
al
wang
et
al
therefor
use
determin
effect
quercetin
vivo
normal
mice
infect
sham
intranas
rout
h
mice
treat
quercetin
propylen
glycol
vehicl
mice
sacrif
day
later
assess
lung
viral
load
anticip
mice
infect
sham
show
infecti
viru
data
shown
mice
infect
treat
vehicl
show
signific
level
ccid
ml
infecti
viru
day
postinfect
fig
day
infect
detect
infecti
viru
observ
previous
newcomb
et
al
hand
mice
treat
quercetin
show
less
log
infecti
viruslung
ie
log
less
viru
compar
vehicletr
mice
day
infect
similarli
quercetintr
mice
also
show
significantli
lower
vrna
level
day
postinfect
compar
vehicletr
mice
fig
determin
whether
observ
decreas
viral
load
also
depend
inhibit
viral
replic
determin
infect
medium
replac
fresh
media
incub
h
quercetin
lm
dmso
ad
cell
total
h
total
protein
isol
subject
western
blot
analysi
use
antibodi
b
c
blot
repres
three
independ
experi
level
negativestrand
rna
mous
lung
anim
treat
vehicl
show
detect
level
neg
strand
vrna
day
infect
fig
decreas
similarli
infect
mice
treat
quercetin
day
postinfect
neither
vehiclenor
quercetintr
mice
show
detect
level
negativestrand
vrna
data
shown
result
impli
model
rv
replic
occur
within
first
h
infect
quercetin
effect
inhibit
process
previous
shown
rv
infect
stimul
lung
chemokin
cytokin
express
newcomb
et
al
determin
whether
quercetin
decreas
rvstimul
chemokin
cytokin
level
determin
protein
level
kc
tnfa
singl
multiplex
elisa
mice
infect
rv
treat
vehicl
show
significantli
increas
level
four
cytokineschemokin
compar
mice
infect
sham
day
day
postinfect
correl
presenc
viru
lung
fig
quercetin
treatment
decreas
level
four
cytokin
rvinfect
mice
impli
quercetin
attenu
rvstimul
proinflammatori
respons
mice
decreas
viral
load
next
measur
mrna
level
repres
type
ifna
iii
ifn
express
depend
gener
doublestrand
rna
intermedi
rv
replic
expect
mice
infect
treat
vehicl
show
significantli
higher
level
ifna
shaminfect
anim
day
postinfect
return
normal
level
day
rv
infect
fig
f
correl
presenc
negativestrand
vrna
lung
mice
treat
quercetin
show
significantli
decreas
level
ifn
compar
rvinfect
vehicl
fig
withdraw
quercetin
sever
hour
rv
infect
limit
rhinoviru
infect
vitro
cell
treat
dmso
lm
quercetin
overnight
cell
shift
fresh
media
without
quercetin
dmso
incub
h
cell
infect
absenc
quercetin
incub
h
infecti
viral
load
determin
describ
fig
vrna
ifn
respons
determin
qpcr
protein
level
determin
elisa
f
data
repres
averag
sd
valu
calcul
three
independ
experi
p
differ
sham
infect
cell
treat
mice
consist
decreas
neg
strand
vrna
quercetintr
mice
previou
studi
demonstr
rv
infect
increas
airway
respons
methacholin
challeng
day
postinfect
newcomb
et
al
return
normal
day
rv
infect
therefor
determin
effect
quercetin
airway
respons
methacholin
day
rv
infect
expect
compar
shaminocul
mice
rvinfect
mice
treat
vehicl
show
increas
airway
respons
particularli
methacholin
dose
mgml
fig
contrast
rvinfect
mice
treat
quercetin
show
level
airway
respons
similar
shaminfect
quercetintr
anim
significantli
lower
observ
rvinfect
vehicl
treat
mice
togeth
result
suggest
vivo
quercetin
treatment
decreas
viral
load
rvstimul
chemokin
cytokin
respons
improv
lung
function
determin
whether
quercetin
pretreat
modul
innat
immun
respons
subsequ
viral
infect
thu
aid
viral
clearanc
mice
pretreat
quercetin
day
follow
washout
period
day
mice
infect
sacrif
h
later
level
proinflammatori
cytokin
ifn
express
vrna
viral
titer
lung
function
determin
observ
mice
infect
show
increas
level
proinflammatori
cytokin
ifn
respons
affect
quercetin
pretreat
fig
addit
quercetin
pretreat
mice
show
similar
level
vrna
viral
titer
mice
treat
vehicl
fig
b
quercetin
pretreat
mice
infect
also
show
airway
hyperrespons
methacholin
challeng
similar
mice
pretreat
vehicl
fig
result
indic
quercetin
treatment
viral
infect
rather
pretreat
effect
vivo
find
surpris
halflif
quercetin
rang
h
boot
et
al
therefor
one
would
expect
plasma
quercetin
level
return
basal
level
h
present
studi
demonstr
quercetin
decreas
rv
infect
multipl
step
viral
life
cycl
quercetin
decreas
viral
endocytosi
inhibit
rvinduc
respons
cultur
airway
epitheli
cell
quercetin
ad
viral
endocytosi
also
decreas
rvstimul
ifn
respons
consist
downstream
effect
quercetin
inhibit
replic
rv
suppress
transcript
rv
genom
quercetin
decreas
rvinduc
cleavag
increas
phosphoryl
final
show
quercetin
treatment
rvinfect
mice
decreas
viral
replic
express
proinflammatori
cytokin
chemokin
airway
hyperrespons
methacholin
challeng
collect
result
suggest
quercetin
may
benefici
limit
viral
replic
reduc
symptom
associ
rv
infect
quercetin
potent
antioxid
possess
antiinflammatori
properti
inhibit
sever
lipid
protein
tyrosin
serin
fig
quercetin
decreas
viral
load
vivo
mice
infect
sham
intranas
rout
two
hour
rv
infect
mice
oral
gavag
quercetin
mgmous
propylen
glycol
pg
day
day
mice
sacrif
infecti
viral
load
determin
measur
ccid
ml
posit
strand
vrna
b
determin
qpcr
neg
strand
vrna
c
detect
qpcr
follow
agaros
gel
electrophoresi
b
data
repres
geomean
rang
data
two
independ
experi
carri
triplic
p
differ
mice
infect
infect
treat
pg
c
pcr
product
two
repres
anim
pg
quercetin
group
show
negativestrand
vrna
rna
threonin
kinas
compet
atp
bind
site
review
william
et
al
fact
potent
inhibitor
ly
design
base
structur
quercetin
vlaho
et
al
other
shown
activ
requir
rv
endocytosi
also
viral
replicationindepend
respons
bentley
et
al
lau
et
al
newcomb
et
al
therefor
treatment
cell
quercetin
prior
rv
infect
could
inhibit
viral
infect
abolish
rv
endocytosi
essenti
initi
step
rv
infect
consist
idea
pretreat
cell
quercetin
decreas
akt
phosphoryl
endocytosi
rv
attenu
associ
chemokin
respons
human
airway
epitheli
cell
addit
inhibit
viral
entri
quercetin
may
also
inhibit
subsequ
step
picornaviru
life
cycl
instanc
quercetin
deriv
shown
inhibit
synthesi
polioviru
rna
castrillo
carrasco
neznanov
et
al
attribut
inhibit
viral
rna
polymeras
pol
castrillo
carrasco
viral
rna
polymeras
pol
requir
convers
viral
genom
creat
negativestrand
rna
serv
templat
gener
posit
strand
viral
genom
castrillo
carrasco
hung
fig
quercetin
decreas
rvstimul
chemokin
cytokin
respons
vivo
mice
infect
treat
quercetin
vehicl
describ
fig
legend
sacrific
mous
lung
excis
homogen
pb
centrifug
supernat
examin
elisa
ad
total
rna
extract
lung
mrna
express
ifna
measur
qpcr
e
f
data
repres
mean
sd
calcul
triplic
experi
p
differ
sham
p
differ
mice
infect
rv
treat
vehicl
et
al
recent
polyphenol
includ
quercetin
shown
increas
zinc
uptak
cell
zinc
ion
shown
inhibit
pol
vitro
hung
et
al
krenn
et
al
sreenivasulu
et
al
quercetin
may
also
interfer
process
rv
polyprotein
rv
proteas
requir
activ
rna
polymeras
hellen
et
al
addit
process
viral
pol
viral
proteas
also
cleav
inhibit
capdepend
host
protein
synthesi
promot
viral
genom
translat
glaser
skern
gradi
et
al
result
demonstr
quercetin
significantli
reduc
neg
posit
strand
viral
rna
associ
reduc
cleavag
reduct
viral
capsid
protein
suggest
quercetin
may
inhibit
initi
polypeptid
process
requir
viral
rna
polymeras
process
cleavag
therebi
block
downstream
step
rv
replic
anoth
possibl
quercetin
may
directli
inhibit
viral
rna
polymeras
therebi
block
genom
translat
synthesi
new
progeni
viru
one
mechan
host
limit
viral
replic
shut
global
protein
synthesi
increas
phosphoryl
jacob
langland
qian
et
al
observ
quercetin
increas
phosphoryl
beyond
stimul
rv
infect
therefor
like
quercetin
also
limit
viral
replic
enhanc
host
innat
immun
respons
recent
replic
enteroviru
member
picornavirida
famili
shown
occur
special
organel
enrich
lipid
gener
iiib
hsu
et
al
rv
replic
requir
orgenel
possibl
quercetin
inhibit
prajda
et
al
may
interfer
format
orgenel
thu
block
viral
replic
togeth
observ
suggest
quercetin
may
interfer
viral
replic
one
mechan
previou
studi
demonstr
infect
normal
mice
transient
replic
increas
level
proinflammatori
cytokin
ifn
lung
increas
airway
respons
methacholin
challeng
newcomb
et
al
sajjan
et
al
wang
et
al
use
model
system
show
first
time
quercetin
inhibit
rv
replic
vitro
also
inhibit
rv
replic
rvinduc
proinflammatori
cytokin
chemokin
express
rvinduc
airway
hyperrespons
vivo
mice
treat
quercetin
show
significantli
decreas
viral
load
diminish
level
fig
compar
vehicletr
anim
rvinfect
mice
treat
quercetin
show
decreas
airway
respons
methacholin
mice
infect
treat
dmso
quercetin
describ
day
mice
anesthet
airway
respons
methacholin
challeng
measur
n
p
differ
sham
infect
mice
p
differ
mice
infect
treat
vehicl
twoway
anova
fig
treatment
quercetin
rv
infect
necessari
limit
rvstimul
cytokin
respons
mice
treat
quercetin
vehicl
describ
fig
day
forti
hour
last
quercetin
vehicl
treatment
mice
infect
sham
sacrif
h
postinfect
lung
harvest
determin
cytokin
protein
elisa
ad
ifn
mrna
express
qpcr
eg
data
repres
mean
sd
calcul
triplic
experi
n
p
differ
sham
anova
negativestrand
rna
decreas
replicationdepend
express
type
type
iii
ifn
wang
et
al
provid
direct
evid
quercetin
effect
inhibit
viral
replic
vivo
addit
quercetin
treatment
decreas
rvinduc
lung
inflamm
evidenc
reduc
express
tnfa
previous
shown
addit
role
lung
inflamm
ligand
tnfa
contribut
rvinduc
airway
hyperrespons
neutrophil
attract
airway
ligand
induc
state
hyperrespons
elabor
tnfa
therefor
decreas
airway
respons
observ
rvinfect
mice
treat
quercetin
may
due
decreas
lung
tnfa
level
quercetin
dihydr
aglycon
passiv
absorb
small
intestin
ingest
quercetin
aglycon
absorb
oppos
natur
occur
quercetin
glycosid
hollman
et
al
plasma
quercetin
level
low
nanomolar
rang
nm
human
consum
normal
diet
estim
provid
mgday
quercetin
boot
et
al
harwood
et
al
upon
supplement
g
quercetin
aglyconeday
increas
plasma
level
lm
boot
et
al
conquer
et
al
previous
shown
treatment
mice
mg
quercetin
yield
total
plasma
quercetin
includ
quercetin
primari
conjug
level
order
nm
ganesan
et
al
nanua
et
al
dose
quercetin
suffici
reduc
lung
inflamm
mous
model
chronic
obstruct
pulmonari
diseas
also
allerg
mous
model
asthma
ganesan
et
al
nanua
et
al
rogerio
et
al
base
present
studi
appear
nanomolar
rang
plasma
quercetin
also
suffici
inhibit
viral
replic
vivo
even
though
higher
concentr
lm
quercetin
requir
vitro
although
precis
explan
unclear
may
depend
differ
stabil
bioavail
quercetin
one
possibl
quercetin
may
absorb
better
vivo
via
small
intestin
compar
respiratori
epitheli
cell
vitro
anoth
possibl
quercetin
metabolit
gener
vivo
may
potent
antivir
agent
parent
compound
quercetin
dihydr
metabol
differ
organ
includ
small
intestin
liver
similar
quercetin
glycosid
harwood
et
al
quercetin
glycosid
fact
precursor
quercetin
aglycon
vivo
quercetin
glycosid
initi
hydrolyz
form
quercetin
aglycon
epitheli
cell
small
intestin
murota
terao
aglycon
gener
metabol
phase
ii
enzym
present
small
intestin
liver
organ
methyl
sulfat
glycosyl
form
one
hour
intragastr
administr
quercetin
rat
major
absorb
quercetin
found
form
quercetin
glucuronid
sulfoglucuronid
sulfat
well
isorhamnet
conjug
justino
et
al
quercetin
glucuronid
propos
potent
modul
reactiv
oxygengener
enzym
quercetin
terao
et
al
studi
requir
assess
antivir
effect
known
quercetin
metabolit
show
quercetin
potent
antioxid
antiinflammatori
agent
also
possess
antirhinovir
effect
querc
fig
treatment
quercetin
rv
infect
necessari
reduc
viral
load
improv
lung
function
mice
treat
quercetin
vehicl
describ
fig
day
forti
hour
last
quercetin
vehicl
treatment
mice
infect
sham
day
mice
sacrif
lung
harvest
determin
vrna
qpcr
infecti
viral
load
b
rest
mice
anesthet
airway
respons
methacholin
challeng
measur
c
n
data
b
repres
rang
median
p
differ
sham
infect
mice
twoway
anova
tin
inhibit
viral
infect
multipl
stage
includ
endocytosi
transcript
viral
genom
viral
protein
synthesi
studi
need
determin
whether
quercetin
benefici
prevent
treat
rhinoviru
infect
reduc
symptom
relat
viral
infect
patient
chronic
lung
diseas
includ
chronic
obstruct
pulmonari
diseas
asthma
cystic
fibrosi
